Targovax – Therapeutic cancer vaccines

Targovax is an innovation driven specialist in immuno-oncology.

People with identical cancer diagnoses do not have identical diseases. Their cells vary in the way they look, function and are seen by the immune system – the body’s own defence against cancer. At Targovax, we are developing cancer specific therapies that activate each patient’s own immune system to fight against their disease.

Read more

Even in late stage cancer patients with low immunogenic tumor types, our virus-based immunotherapy can reinstate the immune system’s ability to recognize and attack cancer cells. In addition, studies with our peptide-based Immunotherapy have shown immune responses in difficult to treat RAS cancer patients.

Read more

8 July Targovax got listed on Oslo Axess. Prospectus for the listing on Oslo Axess and a complete description of all conditions for the subsequent offering can be downloaded here.

Read more